Difference between revisions of "OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings"

From OpenWetWare
Jump to: navigation, search
Line 96: Line 96:
|Dai Lab
|Dai Lab
|Ribosomal protein regulation of p53 and c-Myc in response to ribosomal stress

Revision as of 09:39, 4 March 2011

Equipped with his five senses, man explores the universe around him and calls the adventure Science.  ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       

Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    

Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

  • Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
  • Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:
Email: majordomoATohsu.edu (must be sent as a plain text email)
subject: subscribe oncres
text box: subscribe oncres
  • We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
Fridays 9:30-10:30 AM - see schedule below
Breakfast provided by the Knight!
  • Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

  • Scheduling In Progress


Date Presenters Topic Links & Comments
09/24/2010 Gary Thomas Connecting Membrane Traffic to p53 Homeostasis
10/8/2010 Lopez Lab Mechanisms of deltaNASPP2 function: a novel isoform of the ASPP2 tumor suppressor
10/22/2010 Tania Vu Molecular Imaging of Tyrosine Kinase Signaling Using Quantum Dot Technology
11/12/2010 Jeffrey Tyner Functional Screening for Target Identification in Leukemia Patients A discussion of novel tyrosine kinase targets and therapies for leukemia patients identified by functional screening with siRNA and small-molecule kinase inhibitors.
12/10/2010 Yuangang Liu NF-kappaB repression by PIAS3 mediated RelA sumoylation
1/14/2011 Steven Jacques Early detection of cancer by optical sensing of abnormal nuclear nanoarchitecture
1/28/2011 Laura Hays The Multifunctionality of the Fanconi Anemia/BRCA Pathway in Tumor Suppression
2/11/2011 Thayer Lab Identification of autosomal loci that control chromosome-wide replication timing and stability
2/25/2011 Sears Lab Targeting c-Myc through the tumor suppressor phosphatase, PP2A, for the treatment of breast and pancreatic cancer
3/11/2011 Dai Lab Ribosomal protein regulation of p53 and c-Myc in response to ribosomal stress
3/25/2011 NO MEETING Spring Break
4/8/2011 Lev Fedorov Targeting of Rheb oncogene
4/22/2011 Wong Lab
5/13/2011 Thomas O'Hare
6/10/2011 Lisa Wood